Allergic asthma | 77.9% |
---|---|
Age (years) | 49.8 ± 15.2 |
Age of onset (years) | 23.5 ± 17.0 |
Gender (male) | 44.6% |
Smoker | 4.6% |
Long-acting β2 agonist | 92.8% |
Short-acting β2 agonist (puffs per day) | 1.8 ± 3.2 |
Systemic steroids | 26.1% |
Inhaled steroids | 94.9% |
Theophylline | 21.0% |
Junipers symptoms score | 2.2 ± 1.2 |
ATS | 30.2% |
Serum ECP (μg/l) | 22.9 ± 18.6 |
Blood eosinophils (%) | 5.6 ± 3.8 |
FEV1 (% of predicted normal value) | 83.2 ± 23.5 |